MARIMarinomed Biotech AG

5.000EUR+11.11%Mkt Cap: 10.86M $P/E: 0.51

Marinomed Biotech AG operates as a biopharmaceutical company in Austria, other European countries, and internationally. Its lead products include Budesolv for the treatment of allergic rhinitis in late-stage clinical dev…

HeadlineSourceTime
Older
Börse Social
Börse Social
Börse Social
Börse Social
Börse Social
Börse Social
Börse Social
Börse Social
Börse Social
Börse Social
AAlpenländischer Kreditorenverband
boerse.de
CChemiereport
AAlpenländischer Kreditorenverband
trend.at
KKurier
Wallstreet Online
boerse.de
boerse.de
NNiederösterreichische Nachrichten